ArticlePDF Available

Title: Acetic acid does not reduce triglyceride levels in overweight or obese adults, and it reduces them only marginally in those with diabetes

Authors:

Abstract and Figures

Correspondence on ‘D.S. Valdes, D. So, P.A. Gill, N.J. Kellow, Effect of Dietary Acetic Acid Supplementation on Plasma Glucose, Lipid Profiles, and Body Mass Index in Human Adults: A Systematic Review and Meta-analysis., J. Acad. Nutr. Diet. (2021). https://doi.org/10.1016/j.jand.2020.12.002’ Note: The editor-in-chief forwarded my letter to the authors who will implement my suggestions in a corrigendum to the original article. To avoid redundancy, my letter will not be published, and instead credits to me will be included in the author’s corrigendum. The editor full email is reported at the end of the full document.
Content may be subject to copyright.
Correspondence on ‘D.S. Valdes, D. So, P.A. Gill, N.J. Kellow, Effect of Dietary Acetic Acid
Supplementation on Plasma Glucose, Lipid Profiles, and Body Mass Index in Human Adults: A
Systematic Review and Meta-analysis., J. Acad. Nutr. Diet. (2021).
https://doi.org/10.1016/j.jand.2020.12.002.’
Title: Acetic acid does not reduce triglyceride levels in overweight or obese adults, and it reduces
them only marginally in those with diabetes.
Note: The editor-in-chief forwarded my letter to the authors who will implement my suggestions in a
corrigendum to the original article. To avoid redundancy, my letter will not be published, and instead
credits to me will be included in the author’s corrigendum. The editor full email is reported at the end
of this document.
Dear Editor,
In the Journal of the Academy of Nutrition and Dietetics, Daniela Valdes and colleagues1 report on their
meta-analysis around the effects of dietary acetic acid on various metabolic parameters. They
calculated several meta-analyses by variously combining the 16 included studies involving 910
participants. On carefully examining the results, numerical inaccuracies are revealed in several of the
meta-analyses. In one case, the authors estimated statistically significant large positive effect of acetic
acid in reducing triglyceride levels, where in fact the effect was not statistically significant and of a
lesser magnitude. In other cases the corrected meta-analyses do not significantly change the original
authors’ conclusions, albeit the precision of the effect estimates is reduced.
In the meta-analysis for triglyceride levels in overweight or obese adults, where acetic acid is compared
to placebo or low-dose acetic acid, three studies are included2–4. However, perusing the data from the
third study4 (study ID ‘Park 2014’ in Figure 1), the follow-up values in the meta-analysis have been
swapped between intervention group and control group. Indeed, the study reports that the change from
baseline was -23.17 mg/dL in the placebo group, and 2.75 mg/dL in the acetic acid group, favouring
placebo. Figure 1 reports the corrected meta-analysis. As a result, the effect estimate is not statistically
significant and smaller than the one calculated in the original meta-analysis, i.e., -10.14 mg/dL, 95% CI
[-36.33, 16.06] versus -20.51 mg/dL, 95% CI [-32.98, -8.04], with an obviously much higher statistical
heterogeneity (I2=78% versus I2=4%).
In several other meta-analyses that included the results drawn from a report of a study evaluating the
effect of dates vinegar on several metabolic parameters in adults with diabetes,5 the effect estimates are
imprecise due to the wrong standard deviation values extracted for this included study. Indeed, the
standard deviation values used are of unusually small magnitudes compared to other studies in the
analyses. These values were obviously extracted from a table in the study report. However, the same
report states much larger standard deviations in its abstract. In a personal communication, the article’s
corresponding author has kindly confirmed that the correct standard deviation values are those in the
abstract. After having received from the author all other relevant standard deviation values, the
corrected meta-analyses were calculated, which included data extracted form several others of the
included studies.6–9 The revised results do not differ substantially from the original results, apart from a
reduction of the precision of the estimates, without changing statistical significance. However, one
change worth noticing is that, in adults with diabetes, triglyceride level reduction becomes only
marginally statistically significant, i.e., -7.86 mg/dL, 95% CI [-15.40, -0.31] versus -7.37 mg/dL, 95%
CI [-10.15, -4.59] (Figure 2).
Overall, most of the analyses by Daniela Valdes and colleagues are not significantly affected. However,
the revised estimate of triglyceride level reduction in overweight or obese adults, compared to a large
and statistically significant effect originally reported, showed a lesser effect which was not statistically
significant. In addition, triglyceride level reduction in adults with diabetes becomes only marginally
statistically significant.
Figures
Figure 1. Forest plot for follow-up triglyceride levels in overweight or obese adults.
Figure 2. Forest plot for follow-up triglyceride levels in adults with diabetes.
References
1 Valdes DS, So D, Gill PA, Kellow NJ. Effect of Dietary Acetic Acid Supplementation on Plasma
Glucose, Lipid Profiles, and Body Mass Index in Human Adults: A Systematic Review and
Meta-analysis. J Acad Nutr Diet 2021. DOI:10.1016/j.jand.2020.12.002.
2 Kim EK, An SY, Lee MS, et al. Fermented kimchi reduces body weight and improves metabolic
parameters in overweight and obese patients. Nutr Res 2011; 31: 436–43.
3 Kondo T, Kishi M, Fushimi T, Ugajin S, Kaga T. Vinegar intake reduces body weight, body fat
mass, and serum triglyceride levels in obese Japanese subjects. Biosci Biotechnol Biochem 2009;
73: 1837–43.
4 Park JE, Kim JY, Kim J, et al. Pomegranate vinegar beverage reduces visceral fat accumulation
in association with AMPK activation in overweight women: A double-blind, randomized, and
placebo-controlled trial. J Funct Foods 2014; 8: 274–81.
5 Ali Z, Ma H, Wali A, Ayim I, Rashid MT, Younas S. A double-blinded, randomized, placebo-
controlled study evaluating the impact of dates vinegar consumption on blood biochemical and
hematological parameters in patients with type 2 diabetes. Trop J Pharm Res 2018; 17: 2463–9.
6 Mahmoodi M, Hosseini-zijoud S-M, Hassanshahi G, et al. The effect of white vinegar on some
blood biochemical factors. J Diabetes Endocrinol 2013; 4: 1–5.
7 Nazni P, Singh R, Devi RS, et al. ASSESSMENT OF HYPOGLYCEMIC EFFECTS OF APPLE
CIDER VINEGAR IN TYPE 2 DIABETES. Int J FOOD Nutr Sci 2015; 4: 206–9.
8 Kausar S, Abbas MA, Ahmad H, et al. Effect of Apple Cider Vinegar in Type 2 Diabetic Patients
with Poor Glycemic Control: A Randomized Placebo Controlled Design ®. Int J Med Res Heal
Sci 2019; 8: 149–59.
9 Gheflati A, Bashiri R, Ghadiri-Anari A, Reza JZ, Kord MT, Nadjarzadeh A. The effect of apple
vinegar consumption on glycemic indices, blood pressure, oxidative stress, and homocysteine in
patients with type 2 diabetes and dyslipidemia: A randomized controlled clinical trial. Clin Nutr
ESPEN 2019; 33: 132–8.
Letter from editor-in-chief
Dear Mr. Suadoni,
We appreciate you submitting your Letter to the Editor “Acetic acid does not reduce triglyceride levels
in overweight or obese adults, and it reduces them only marginally in those with diabetes." Your letter
(without your name) was sent to the authors of the article. The authors were very appreciative of your
careful review of the data and for identifying an error which they indicated occurred during the data
extraction and verification process. The authors contacted Ali and colleagues to request the correct
standard deviations so that they could amend their original forest plots. In addition, the authors of the
other included studies were contacted to confirm their results were published correctly. A formal
correction has been submitted by Kellow et al to be published in the Journal with an updated summary
results table. The corrigendum is attached for you to review.
To avoid redundancy, the Journal plans to publish only the corrigendum rather than the two letters and
the corrigendum. You would be given credit in the corrigendum for bringing this error to the attention
of the authors.
Please let me know if you have any concerns regarding this process.
Again, we so appreciate your bringing this to our attention.
Sincerely,
Linda Snetselaar, PhD, RDN, LD
Editor-in-Chief
Journal of the Academy of Nutrition and Dietetics
ResearchGate has not been able to resolve any citations for this publication.
Article
Full-text available
Background Acetic acid is a short-chain fatty acid that has demonstrated biomedical potential as a dietary therapeutic agent for the management of chronic and metabolic illness comorbidities. In human beings, its consumption may improve glucose regulation and insulin sensitivity in individuals with cardiometabolic conditions and type 2 diabetes mellitus. Published clinical trial evidence evaluating its sustained supplementation effects on metabolic outcomes is inconsistent. Objective This systematic review and meta-analysis summarized available evidence on potential therapeutic effects of dietary acetic acid supplementation via consumption of acetic acid–rich beverages and food sources on metabolic and anthropometric outcomes. Methods A systematic search was conducted in Medline, Scopus, EMBASE, CINAHL Plus, and Web of Science from database inception until October 2020. Randomized controlled trials conducted in adults evaluating the effect of dietary acetic acid supplementation for a minimum of 1 week were included. Meta-analyses were performed using a random-effects model on fasting blood glucose (FBG), triacylglycerol (TAG), high-density lipoprotein (HDL), low-density lipoprotein (LDL), glycated hemoglobin (HbA1c), body mass index (BMI), and body fat percentage. Statistical heterogeneity was assessed by calculation of Q and I² statistics, and publication bias was assessed by calculation of Egger’s regression asymmetry and Begg’s test. Results Sixteen studies were included, involving 910 participants who consumed between 750 and 3600 mg acetic acid daily in interventions lasting an average of 8 weeks. Dietary acetic acid supplementation resulted in significant reductions in TAG concentrations in overweight and obese but otherwise healthy individuals (mean difference [MD] = −20.51 mg/dL [95% confidence intervals = −32.98, −8.04], P = .001) and people with type 2 diabetes (MD = −7.37 mg/dL [−10.15, −4.59], P < .001). Additionally, acetic acid supplementation significantly reduced FBG levels (MD = −35.73 mg/dL [−63.79, −7.67], P = .01) in subjects with type 2 diabetes compared with placebo and low-dose comparators. No other changes were seen for other metabolic or anthropometric outcomes assessed. Five of the 16 studies did not specify the dose of acetic acid delivered, and no studies measured blood acetate concentrations. Only one study controlled for background acetic acid-rich food consumption during intervention periods. Most studies had an unclear or high risk of bias. Conclusion Supplementation with dietary acetic acid is well tolerated, has no adverse side effects, and has clinical potential to reduce plasma TAG and FBG concentrations in individuals with type 2 diabetes, and to reduce TAG levels in people who are overweight or obese. No significant effects of dietary acetic acid consumption were seen on HbA1c, HDL, or anthropometric markers. High-quality, longer-term studies in larger cohorts are required to confirm whether dietary acetic acid can act as an adjuvant therapeutic agent in metabolic comorbidities management.
Article
Full-text available
Type 2 diabetes is one of the most prevalent endocrine disorders worldwide. Traditionally, herbal plants and their derivatives are used to lessen complications of type 2 diabetes. The hypoglycemic and hypolipidemic properties have been reported for vinegar, but some cases of discrepant effects were also observed. In the current study, the impact of apple vinegar on some hematological and blood biochemical factors in type 2 diabetic patients was investigated. In this trial study, sixty patients with type 2 diabetes were divided into two groups. The first group took 15 ml of vinegar with their middle meal for one month. The second group received water as placebo. At the beginning and end of the study, blood samples were collected and biochemical factors including fasting blood sugar (FBS), glycated hemoglobin (HbA1c), triglycerides (TG), total cholesterol, low-density lipoprotein-cholesterol (LDL-C), high-density lipoprotein-cholesterol (HDL-C), urea, creatinine (Cr), uric acid, aspartate transaminase (AST), alanine transaminase (ALT), alkaline phosphatase (ALP) and complete blood count (CBC) were evaluated. Findings showed that FBS (P=0.006), HbA1c (P=0.002), MCV (P=0.0001) and mean cell hemoglobin (MCH; P=0.002) decreased where platelets (PLT) (P=0.005) increased significantly in first group. There was no significant difference in the studied parameters in placebo group. Based on the results of this study, it can be concluded that vinegar is a hypoglycemic agent that can be applied for treatment of type 2 diabetes.
Article
Background: Some foods and drinks contain special ingredients, causing impressive effects on human health. The aim of the current study was to assess the health effects of apple vinegar in patients with diabetes and dyslipidemia. Method: Seventy participants with type 2 diabetes and hyperlipidemia were randomly assigned into an intervention and control group in order to assess the effect of 20 ml apple vinegar per day using an 8-week parallel study. Fasting blood sugar (FBS), homeostasis model assessment for insulin resistance (HOMA-IR), homeostasis model assessment for b-cell function (HOMA-B), quantitative insulin sensitivity checks index (QUICKI), insulin, malondialdehyde (MDA), 2,20-Diphenyl-1- picrylhydrazyl (DPPH), homocysteine, systolic blood pressure (SBP), and diastolic blood pressure (DBP) were measured at the beginning and end of the study. Results: The intervention with apple vinegar could significantly improve FBS (mean change: -10.16 ± 19.48 mg/dl, p = 0.006) and DPPH (mean change: 16.58 ± 11.56, p < 0.001) within intervention group and in comparison with control group (p < 0.001). Additionally, the significant increase of MDA in control group (p < 0.05) caused a considerable difference between two groups. Glycemic indices containing insulin, HOMA-IR, HOMA-B, and QUICKI decrease significantly in both groups (p < 0.05). No considerable effect was observed on blood pressure and homocysteine in intervention group as well as control group. Conclusion: This trial provided some evidences that apple vinegar consumption may cause beneficial effects on glycemic indices and oxidative stress in individuals with diabetes and dyslipidemia. This randomized clinical trial was registered in the Iranian Registry of Clinical Trials (https://www.irct.ir/) as 2013070710826N5.
Article
Purpose: To determine the effects of dates vinegar on blood biochemical and hematological parameters in type 2 diabetic subjects. Methods: Current research focused on fifty-five subjects having blood sugar more than126 mg/dL. Participants ingested dates vinegar (20 mL) daily into their normal diets for a period of 10 weeks. Glycated hemoglobin (HbA1c), fasting blood sugar (FBS), total cholesterol, high-density lipoprotein (HDL), low-density lipoprotein (LDL), creatinine (Cr), urea, complete blood count (CBC), alanine transaminase (ALT), aspartate transaminase (AST), alkaline phosphatase (ALP), potassium and folate levels were analyzed before, after 5 weeks and after the experiment Results: Dates vinegar improved the blood concentrations of HbA1c (6.80 ±2.34 to 6.17 ± 2.14 (%)), FBS (171.43 ±36.74 to 147.56 ± 38.86 mg/dL,p=0.001), TC (218.10 ± 16.9 to 191.14 ± 14.23 mg/dL, p<0.001), ALT (24.94 ± 5.03 to 21.88±5.08 IU/L, p=0.002) and ALP (264.32± 45.26 to 257.30 ±44.21 IU/L) and folate (34.6 ± 6.6 to 41.7 ± 6.5 nmol/ L,p<0.001). Conclusion: Dates vinegar significantly improved the total cholesterol.The other blood biochemical and hematological factors were also improved however; the improvements were not significant.
Article
Acetic acid (AcOH), a main component of vinegar, recently was found to suppress body fat accumulation in animal studies. Hence we investigated the effects of vinegar intake on the reduction of body fat mass in obese Japanese in a double-blind trial. The subjects were randomly assigned to three groups of similar body weight, body mass index (BMI), and waist circumference. During the 12-week treatment period, the subjects in each group ingested 500 ml daily of a beverage containing either 15 ml of vinegar (750 mg AcOH), 30 ml of vinegar (1,500 mg AcOH), or 0 ml of vinegar (0 mg AcOH, placebo). Body weight, BMI, visceral fat area, waist circumference, and serum triglyceride levels were significantly lower in both vinegar intake groups than in the placebo group. In conclusion, daily intake of vinegar might be useful in the prevention of metabolic syndrome by reducing obesity.
Fermented kimchi reduces body weight and improves metabolic parameters in overweight and obese patients
  • E K Kim
  • An Sy
  • M S Lee
Kim EK, An SY, Lee MS, et al. Fermented kimchi reduces body weight and improves metabolic parameters in overweight and obese patients. Nutr Res 2011; 31: 436-43.